Hanaa Addai Ali

Publications

• Research   
  Association between Levels of Serum Midkine with Insulin Resistance as New Potential Diagnostic Marker for Thyroid Cancer in its Early Stages
  Author(s): Noor Ali Gebur and Hanaa Addai Ali*
  
  Background and aim: Thyroid cancer is the most frequent endocrine cancer on the world. This malignancy accounts for 1.3 percent of all cancers and accounts for roughly 0.5 percent of cancer-related deaths worldwide each year. Midkine are implicated in the spread of cancer and orchestrate development, cell survival, neural expansion, and inflammation. Its expression is confined to the kidney, lung, thyroid, and small intestine in healthy adult tissue. In this study, we aimed to evaluate the Serum Midkine in patients with newly diagnosed thyroid cancer, and to identify any correlation with biochemical parameters studied. Materials and methods: A case-control study design involved 120 Iraqi subjects, 60 of whom had thyroid cancer (48 females and 12 males) to compare the results with 60 healthy adults (50 females and 10 males) whose ages were cl.. Read More»
  

  Abstract HTML PDF